Recently, Xu et al. have reported they have utilized CRISPR/Cas9 to edit CCR5 gene in HSPCS and transplant the cells to a acute lymphoblastic leukemia (ALL) and HIV-1 bearing 27 years old male in China. The gene discussed is CCR5; the disease is acute lymphoblastic leukemia.